Insmed, Inc. (INSM): Price and Financial Metrics

INSM POWR Grades

• INSM scores best on the Value dimension, with a Value rank ahead of 60.28% of US stocks.
• INSM's strongest trending metric is Quality; it's been moving down over the last 177 days.
• INSM ranks lowest in Momentum; there it ranks in the 4th percentile.

INSM Stock Summary

• INSMED INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 5.45% of US listed stocks.
• With a price/sales ratio of 13.51, INSMED INC has a higher such ratio than 92.18% of stocks in our set.
• INSM's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.73% of US stocks.
• If you're looking for stocks that are quantitatively similar to INSMED INC, a group of peers worth examining would be CYTK, FGEN, APLT, NVAX, and CPTN.
• INSM's SEC filings can be seen here. And to visit INSMED INC's official web site, go to www.insmed.com.

INSM Valuation Summary

• In comparison to the median Healthcare stock, INSM's price/earnings ratio is 118.46% lower, now standing at -4.9.
• Over the past 243 months, INSM's price/sales ratio has gone down 737.2.

Below are key valuation metrics over time for INSM.

INSM Growth Metrics

Its 4 year cash and equivalents growth rate is now at 240.87%.
• Its 2 year cash and equivalents growth rate is now at 20.23%.
• Its year over year cash and equivalents growth rate is now at 25.86%.

Over the past 70 months, INSM's revenue has gone up $245,358,000.

The table below shows INSM's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	245.358	-400.439	-481.534
2022-09-30	242.182	-381.422	-434.389
2022-06-30	221.209	-367.039	-415.958
2022-03-31	201.354	-340.182	-437.634
2021-12-31	188.461	-363.302	-434.654
2021-09-30	173.752	-345.962	-423.889

INSM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• INSM has a Quality Grade of C, ranking ahead of 31.6% of graded US stocks.
• INSM's asset turnover comes in at 0.172 -- ranking 207th of 682 Pharmaceutical Products stocks.
• CYRX, CTLT, and ACOR are the stocks whose asset turnover ratios are most correlated with INSM.

The table below shows INSM's key quality metrics over time.